ТАКТИКА ВЕДЕНИЯ БОЛЬНЫХ ПОЖИЛОГО ВОЗРАСТА С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ В ПРАКТИКЕ СЕМЕЙНОГО ВРАЧА

Коваленко Л. И., Вовк К. В., Сокруто О. В., Николенко Е. Я.

ОБЗОРЫ ЛИТЕРАТУРЫ

Научная статья.

Переход человека в категорию лиц пожилого возраста сопроврждается повышением проблем со здоровьем, среди которых не последнее место занимает артериальная гипертензия. Много исследований свидетельствует о том, что эффективность антигипертензивной терапии повышается при одновременном использовании комбинации препаратов разных классов. Если после приема одного антигипертензивного препарата невозможно достичь целевого уровня артериального давления, должен быть решен вопрос о дополнении в схему лечения еще одного препарата другого класса в оптимальной дозе.

антигипертензивная терапия, пациенты пожилого возраста, комбинация препаратов

1. Akram J. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy : the NATIVE study / J. Akram // J. Hypertens. - 2006. - Vol. 24. - P. 1267 - 1275.
2. Beckett N. S. For the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older / N. S. Beckett, R. Peters, A. E. Fletcher [et al.] // N. Engl. J. Med. - 2008. - Vol. 359. - P. 971 - 974.
3. Blacher J. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients / J. Blacher,J. A. Staessen [et al.] // Arch. Intern. Med. - 2000. - Vol. 60. - P. 1085 - 1089.
4. Brennan P. Fime spent moving is related to systolic blood pressure among older women / P. Brennan, L. S. Pescatello, R. W. Bohannon[et al.] // Prev. Cardiol. - 2005. - Vol. 8. - P. 160 - 164.
5. Ferrier K. E. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension /K. E. Ferrier, F. K. Waddell, C. D. Gatzka [et al.] // Hypertension. - 2011. - Vol. 38. - P. 222 - 226.
6. Force M. Guidelines for the management of arterial hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / M. Force, G. Mancia, G. De Backer[et al.] // Eu. Heart J. - 2007. - Vol. 28 (12). - P. 1462 - 1536.
7. Franklin S. S. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensive Analysis based on National Health and Nutrition E x amination Survey (NHANES) 111 / S. S. Franklin [et al.] // Hypertension. -2011. - Vol. 37. - P. 869 - 874.
8. Gordon S. Management of hypertension in the elderly patient / S. Gordon // Clinical Interventions in Aging. - 2009. -Vol. 9. - P. 379 - 390.
9. Gueyffer F Antihypertensive drugs in very old people : a subgroup meta-analysis of randomized controlled trials / F Gueyffer, C. Bulpitt [et al.] // Lancet. - 2009. - Vol. 353. - P. 793 - 796.
10. He F J. Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension / F. J. He, N. D. Markandu, G. A. MacGregor // Hypertension. - 2005. - Vol. 46. - P. 66 - 70.
11. Kaplan N. The CARE Study : A postmarketing evaluation of ramipril in 11 100 patients / N. Kaplan // Clin. Ther. - 2005. -Vol. 18 (4). - P. 658 - 670.
12. Lindholm L. H. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis /L. H. Lindholm, В. Carlberg, O. Samuelsson // Lancet. - 2005. - Vol. 366. - P. 1545 - 1553.
13. Lithell H. The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomised double-blind intervention trial / H. Lithell, L. Hansson, I. Skoog [et al.] // J. Hypertens. - 2003. - Vol. 21. - P. 875 - 886.
14. Mckenzie I. S. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension / I. S. Mckenzie, СМ. McEniery, Z. Dhakam [et al.] // Hypertension. - 2009. - Vol. 54. - P. 409 - 413.
15. Myers M. G. Use of automated office blood pressure measurement to reduce the white coat response / M. G. Myers [et al.] // J. Hypertens. - 2009. - Vol. 27. - P. 280 - 286.
16. Ohmori M. Stereoselective pharmacokinetics of Amlodipine in elderly hypertensive patients / M. Ohmori, M. Arakawa, K. Harada [et al.] // American Journal of Therapeutics. - 2013. - Vol. 10. - P. 29 - 31.
17. Redon J. Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly / J. Redon, I. Cea-Calvo, B. Mareno [et al.] // J. Hypertens. - 2006. - Vol. 26. - P. 1757 - 1764.
18. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension : final results of the Systolic Hypertension in the Elderly Program (SHEP) // JAMA. - 2011. -Vol. 265. - P. 3255 - 3264.
19. Staessen J. A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension / J. A. Staessen, R. Fagard, L. Thijs [et al.] // Lancet. - 2007. - Vol. 350. - P. 757 - 764.
20. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) // JAMA. - 2012. - Vol. 288. - P. 2981 -2997.
21. The RACE (Ramipril Cardioprotective Evaluation) // J. Hypertens. - 2005. - Vol. 13. - P. 1325-1334.
22. The TRANSCEND investigators. Effect of the angiotensin-receptor blocker telmisartan on cardiovascular events in highrisk patients intolerant to angiotensin-converting enzyme inhibitors : a randomised controlled trail // Lancet. - 2008. -Vol. 372. - P. 1174 - 1183.

«Вестник проблем биологии и медицины» Выпуск 2 Том 3 (120), 2015 год, 20-24 страницы, код УДК 616. 12 - 008. 331. - 1 - 085. 002. 25